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Vpx facilitates HIV-2 nuclear localization by a poorly understood mechanism. We have compared Vpx to an NMR structure HIV-1 Vpr in a
central helical domain and probed regions of Vpx by insertional mutagenesis. A predicted loop between helices two and three appears to be
unique, overlapping with a known novel nuclear localization signal. Overall, Vpx was found to be surprisingly flexible, tolerating a series of large
insertions. We found that insertion within the polyproline-containing C-terminus destabilizes nuclear localization, whereas mutating a second helix
in the central domain disrupts viral packaging. Other insertional mutants in the predicted loop and in a linker region between the central domain
and the C-terminus may be useful as sites of intramolecular tags as they could be packaged adequately and retained preintegration complex
associated integration activity in a serum starvation assay. An unexpected result was found within a previously defined nuclear localization motif
near aa 71. This mutant retained robust nuclear localization in a GFP fusion assay and was competent for preintegration complex associated
nuclear import. In summary, we have modeled helical content in Vpx and assessed potential sites of intramolecular tags which may prove useful
for protein–protein interactions studies.
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Infection of non-dividing cells is a hallmark of the
lentiviruses (HIV-1, HIV-2, and the simian immunodeficiency
viruses), setting them apart from oncoretroviruses which
require mitosis (Lewis and Emerman, 1994). Infection of
quiescent cells plays an important role in HIV transmission,
dissemination, pathogenesis, and latency. Key to this process
is a large nucleoprotein preintegration complex (PIC) which
directs the newly reverse transcribed viral cDNA through
presumably intact nuclear membranes (reviewed in Greber
and Fornerod, 2005, and Fouchier and Malim, 1999). The
PIC remains poorly characterized but likely contains viral
integrase, matrix, the accessory proteins Vpr or Vpx of HIV-1
or HIV-2/SIV, respectively, and viral cDNA (Bukrinsky et al.,
1993; Farnet and Haseltine, 1991; Karageorgos et al., 1993;
Miller et al., 1997). Host barrier-to-auto integration factor,⁎ Corresponding author. Fax: +1 314 747 2120.
E-mail addresses: lmahnke@im.wustl.edu (L.A. Mahnke),
lratner@im.wustl.edu (L. Ratner).
0042-6822/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.12.023histones, and the DNA-binding protein HMG Y(I) also assist
with PIC function (Karageorgos et al., 1993; Chen and
Engelman, 1998; Farnet and Bushman, 1997; Harris and
Engelman, 2000; Hindmarsh et al., 1999; Li et al., 2000; Lin
and Engelman, 2003).
HIV-2 and other members of the lentivirus family that
includes SIVmac and SIVsm encode a small accessory protein
called Vpx. This protein is homologous to HIV-1 and SIV Vpr
and likely arose by at least one distant gene transfer event
(Tristem et al., 1992, 1998; Sharp et al., 1996). HIV-2 also
encodes a Vpr protein, however, it is Vpx that plays an
important role in nuclear targeting similar to that of HIV-1 Vpr
(Fletcher et al., 1996; Le Rouzic and Benichou, 2005; Pancio et
al., 2000; Popov et al., 1998a). Thus, the nuclear localization
and cell cycle arrest functions of HIV-1 Vpr appear to be split in
HIV-2 between Vpx and Vpr, respectively (Fletcher et al.,
1996). Furthermore, Vpx is necessary for replication in
macrophages (Fletcher et al., 1996; Pancio et al., 2000).
These observations, together with studies linking Vpx (Hansen
and Bushman, 1997) or Vpr to PICs, suggest an important role
for Vpx in nuclear localization during HIV-2 infection.
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enhances viral dissemination and pathogenesis (Igarashi et al.,
1998; Hirsch et al., 1998). In vitro, while dispensible on
laboratory adapted cell lines (Hu et al., 1989; Guyader et al.,
1989; Marcon et al., 1991), Vpx is required for HIV-2 and
SIV replication in freshly isolated peripheral blood mononu-
clear cells (PBMCs), CD4 cells, lymphoid tissue, and
macrophages (Park and Sodroski, 1995; Pancio et al., 2000;
Akari et al., 1992; Kawamura et al., 1994; Kappes et al.,
1991; Yu et al., 1991; Tokunaga et al., 1997; Ueno et al.,
2003; Rücker et al., 2004). More recently, Vpx and HIV-1
Vpr have been implicated in up-regulation of nuclear
localization in dividing lymphocytes, suggesting that even
in a mitotic cell, the accessory proteins assist in nuclear
targeting (Ueno et al., 2003; Iijima et al., 2004). Finally, Vpx
and HIV-1 Vpr are packaged into virions via an interaction
with the p6 domain of Gag, positioning them for participation
in PIC-associated nuclear localization upon target cell entry
(Popov et al., 1998a; Kewalramani and Emerman, 1996;
Horton et al., 1994; Wu et al., 1994; Jin et al., 2001; Pancio
and Ratner, 1998; Selig et al., 1999; Accola et al., 1999;
Mahalingam et al., 2001).
The molecular mechanism of HIV PIC nuclear transport
remains unclear. Although nuclear localization signals (NLS)
have been described in both matrix and integrase, these are
neither necessary nor sufficient for nuclear transport (reviewed
in Greber and Fornerod, 2005; Stevenson, 1996; Sherman and
Greene, 2002). Both Vpr and Vpx localize to the nucleus or
when overexpressed in the absence of Gag (Pancio et al.,
2000; Mahalingam et al., 2001), but neither protein contains a
classic NLS. Vpr binds to importin-α (Popov et al., 1998a)
and can interact with importin-β as well as dock with the
nuclear pore (Popov et al., 1998b; Kamata et al., 2005; Gallay
et al., 1997; Vodicka et al., 1998; Fouchier et al., 1998).
Despite these findings, there is conflicting evidence implicat-
ing the importin-α/β nuclear import complex in Vpr-directed
PIC transport (Popov et al., 1998b; Jenkins et al., 1998). HIV
PICs have also been observed to use importin 7 (Fassati et al.,
2003), although this pathway appears dispensible (Zielske and
Stevenson, 2005). Furthermore, Vpr is known to interact with
nucleoporins (Le Rouzic et al., 2002; Popov et al., 1998b).
Vpr induces nuclear membrane herniations, which might
contribute to the nuclear localization process (de Noronha et
al., 2001). Finally, HIV-1 PICs interact with microtubules,
which are observed to facilitate their transfer within 75 min
after entry to the nuclear membrane region (McDonald et al.,
2002).
Various sites in Vpr have been implicated in nuclear
localization by mutagenesis (reviewed in Le Rouzic and
Benichou, 2005). However, structural studies and the analysis
of various mutants suggest that the integrity of a central three
helix bundle is important to Vpr function (Morellet et al., 2003).
For Vpx, deletions and mutations in the unique C-terminal
region, which contains a stretch of polyproline not found in Vpr,
are known to destabilize nuclear localization (Pancio et al.,
2000; Mahalingam et al., 2001). Interestingly, minimal peptide
motifs near aa 65–75 have been shown to be sufficient fornuclear localization when fused to larger proteins (Mahalingam
et al., 2001; Rajendra Kumar et al., 2003; Belshan and Ratner,
2003). Phosphorylation of Vpx has been implicated in nuclear
transport of SIV PICs (Rajendra Kumar et al., 2005), as has
binding to the host cytoskeleton component actinin (Mueller et
al., 2004).
We sought (1) to compare HIV-2 Vpx with HIV-1 Vpr in
order to map structural domains and (2) to probe regions by
insertional mutagenesis. One goal is to find stable insertion
sites that can be used as intramolecular tags. First, we
compared a central domain against a three helix structure of
HIV-1 Vpr. Next, we created a series of insertions in this
region and in the C-terminus and examined Vpx packaging,
GFP-tagged nuclear localization, and PIC-associated nuclear
import. Vpx was found to be surprisingly flexible, tolerating
an array of large insertions. A predicted loop and a linker
between the central helical region and the C-terminus appear
to be useful sites for engineering intramolecular tags.
Results
Predicting tertiary structure in Vpx
We sought to compare Vpx in a central region to HIV-1
Vpr and noticed that aa 23–87 in Vpx could be simply
threaded against a structure of HIV-1 Vpr (Morellet et al.,
2003) if five amino acids, Vpx 60–64, were taken into
account as a loop (data not shown). This 5-aa sequence is
predicted to be coil by various secondary structure
prediction algorithms (Fig. 1A). Low complexity regions,
such as this, can often tolerate variability. We next aligned
all of aa 23–87 against Vpr by allowing for a 2-aa
adjustment in the low complexity region and submitted the
alignment (Fig. 1B) for homology modeling by 3D Jigsaw
(Bates and Sternberg, 1999; Bates et al., 2001). The model
(schematic shown in Fig. 1C) predicts a three helix bundle
stabilized by intramolecular hydrophobic contacts and
anchored across helices 1 and 3 by the extremely well-
conserved histidines, H39 and H82 (Fig. 1D) in addition to
L40 and V83, which are generally conserved as hydrophobic
residues in these positions. However, K68 tends to
destabilize the hydrophobic core in this model. For this
reason, we sought gap building to better account for the low
complexity loop using the Robetta server (Kim et al., 2004;
Chivian et al., 2003; Rohl et al., 2004), which uses Rosetta
(Simons et al., 1997). The process uses energy-minimized
constraints by simulated annealing to generate a comparative
model and then builds gaps both by ab initio and homology
modeling based on peptide fragments. The result (Figs. 1E
and F) predicts similar helical content but shifts the loop
slightly toward the C-terminus at aa 60–71 compared to the
previous models.
Recently, a leucine zipper homodimer has been demonstrat-
ed for helix three in HIV-1 Vpr by NMR (Bourbigot et al.,
2005). We attempted to model the corresponding region in Vpx
(data not shown). While hydrophobic residues L72, I74, and
V79 could be modeled, K68 tends to disrupt the dimer.
Fig. 1. Vpx/Vpr homology region; Vpx structural predictions. (A) ROD HIV-2 Vpx secondary structure prediction by PsiPred (McGuffin et al., 2000); aa 24–87 are
shown; H represents helix, C represents random coil; the remainder of the N- and C-terminal sequences are predicted to be random coil. (B) Alignment of the region in
Vpx (top strand) with HIV-1 Vpr (bottom strand), as predicted by Domain Fishing, with manual readjustment of the gap region, as described in Materials and methods.
Solid lines indicate identity, dark and light dashes indicate similarity. (C) Vpx aa 1–112 schematic. α-Helical regions predicted by 3DJigsaw, as described in Materials
and methods, are indicated as H1–3. Positions H39, P41, and H82 are shown. (D) Remote homology sensing based on multiple Vpx and Vpr sequence alignments;
positions H39 and H82 are indicated. (E) Vpx aa 1–112 schematic, as in panel C. α-helical regions predicted by Robetta, as described in Materials and methods, are
depicted. (F) α-Helical region aa 23–87, as in panel E, as modeled by Robetta. The figure was rendered with DeepView (Guex and Peitsch, 1997). (G) Vpx consensus
from multiple sequence alignments of HIV-2 and SIV Vpx.
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tryptophan on the opposite helix three with which to make
stacking interactions. Thus, a leucine zipper like dimer for Vpx
helix three seems unlikely.
The predicted 60–71 loop, which contains five additional
amino acids relative to Vpr (Figs. 1E and F), coincides
precisely with a recently defined minimal nuclear localization
motif, aa 65–72 (Rajendra Kumar et al., 2003; Belshan and
Ratner, 2003). This region contains 68-KYRY-71 which is
highly conserved among Vpx sequences from a range of
isolates (Fig. 1G) but is not found in Vpr. Thus, the Vpx NLSappears to be both structurally and functionally distinct
compared to Vpr.
The C-terminal domain can be expected to form a left-
handed type II polyproline helix, based on thermodynamic and
structural studies of similar peptides (Rath et al., 2005;
Sreerama and Woody, 1994). The linker region between the
helical core and the polyproline tail (residues 91–101) can be
predicted as a loose coil, given the presence of five glycines and
one proline. Overall, such an extended structure is ideal as a
protein-binding interface, given potential favorable entropic
binding costs.
Fig. 2. Insertion mutations. (A) Positions and sequence of transposition-mediated 19-aa insertions and polyhistidine insertion in the Vpx sequence. H1–3 correspond to
helices as in Figs. 1F. (B) Western blots of purified viral particles probed for Vpx (upper) or viral capsid (CA) (lower). (C) Cellular lysates used to produce virus as in
panel B. Note that a lower resolving SDS-PAGE gel was used, and thus, the migration patterns appear similar for the various mutants; Western blots probed for Vpx or
CA. (D) Plot of normalized ratio of Vpx or Vpx mutants:CA localized to viral particles.
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for Vpx viral particle recruitment versus nuclear localization
We hypothesized that by creating insertional mutations in
Vpx, we could study functional domains and at the same time
find favorable sites for intramolecular tagging. A series of 19-
aa insertions were generated by transposon-based mutagene-
sis, and a panel was chosen: Insertion (Ins) 52, at the
predicted second helix; Ins 71, within the NLS; Ins 91, at thelinker between helix three and the polyproline tail; and Ins
106, within the polyproline motif (Fig. 2A). It should be noted
that the transposition mechanism leaves small duplications.
For example, Ins 52 caused duplication of 51-SW-52, whereas
Ins 71 resulted in duplication of 69-YRY-71 (Fig. 2A). Ins
106 recreated proline 107, because of the wobble base at
codon 106, and had the net effect of duplicating 105-PP-106
(Fig. 2A). Next, a His5 insertion adjacent to H57 was created
by site-specific mutagenesis. This site was chosen because
Fig. 4. PIC-mediated viral nuclear localization in non-dividing cells. Plots of
total chromosomal integrations, as measured by an Alu-based method, for wild-
type or mutant Vpx viruses.
Fig. 3. Localization of Vpx mutants by GFP fusion. HeLa cell transfections visualized by fluorescent microscopy. Arrows point to cytoplasmic inclusion bodies.
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of helix 2.
The insertion mutants were analyzed for viral particle
incorporation by constructing mutant HIV-2 molecular clones
and transfecting them into 293T cells. Viral particles were
isolated. As shown in Fig. 2B, all of the mutant proteins were
packaged. After normalizing for total Vpx to HIV-2 capsid (CA)
ratios expressed in the cellular lysates (Fig. 2C), the efficiency
of Vpx recruitment was assessed by taking the ratio of Vpx/CA
in the viral particles (Fig. 2D). Ins 52 was the most severely
compromised, packaged at 6% compared to wild type, whereas
Ins 57, 71, 91, and 106 were moderately decreased; 55, 20, 30,
and 31%, respectively.
Next, we studied nuclear localization by overexpressing the
insertion mutants as GFP fusions. As shown in Fig. 3, wild-type
Vpx accumulated in the nucleus, as expected. Tiny cytoplasmic
inclusion bodies were observed (Fig. 3, arrows). Ins 52
localized to the nucleus, also with scattered punctuate
cytoplasmic inclusions (Fig. 3, arrows). Ins 57 and 106 showed
relatively poor nuclear localization, with more diffuse cyto-
plasmic distribution (Fig. 3). Ins 91 consistently localized to the
nucleus but caused a toxic appearance to cells (Fig. 3). The most
striking result was Ins 71, which localized uniformly to the
nucleus and did not form inclusion bodies (Fig. 3).
Integration activity of the insertion mutants
Next, the insertion mutants were studied in an infection assay
in serum-starved cells to test for active nuclear localization in
the context of the HIV-2 PIC. In this assay, amphotropic MLV-
pseudotyped HIV-2 viruses are used to infect arrestedmonocytic U937 cells during a short incubation. A nested
PCR technique similar to that described by Brussel et al. (2005)
counts integration events in the chromosomal DNA, presum-
ably reflecting successful negotiation of the nuclear envelope.
The first round of PCR is a linear round using primers against
the repetitive and widely distributed Alu chromosomal
sequences together with a tagged HIV-2 LTR primer. The
second round is a quantitative, real-time, round using primers
complementary to the tag and the LTR together with an internal
fluorescent probe. As shown in Fig. 4, wild-type Vpx virus is
much more efficient than ΔVpx for nuclear localization in this
assay (lanes 1 and 2), as expected. Ins 106 showed severely
compromised function, similar to ΔVpx (Fig. 4, lane 7). Ins 52
was strongly reduced (Fig. 4, lane 3), whereas Ins 57, 71, and 91
were moderately decreased relative to wild-type virus nuclear
localization (Fig. 4, lanes 4–6).
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Structural predictions in Vpx
Because the modeled helical region (Fig. 1F) coincides
precisely with the most highly conserved sequences between
Vpx and Vpr, a three helix bundle structure seems likely.
Furthermore, the fact that H39 and H82 are extremely well
conserved across all Vpx and Vpr sequences (Fig. 1D) points to
a structural role for such a configuration. In fact, a recent study
showed SIV Vpx H82A to be compromised for nuclear
localization and mutant virus that was deficient for replication
in macrophages (Mahalingam et al., 2001). Considering diverse
Vpx sequences, as shown in Fig. 1G, it is apparent that
hydrophobic residues predicted to stabilize the central core are
well conserved, including residues 25I, 29V, 32I, 37V, 40L,
44L, 45I, 48V, 72L, 74I, and 75M.
Proline at position 41 is predicted to adopt a trans-
configuration stabilizing the first turn in the helical bundle,
analogous to Vpr P35 (Bruns et al., 2003; Morellet et al., 2003)
(Fig. 1F). Proline in this region is highly conserved among Vpx
and Vpr sequences, at various positions within the turn.
Interestingly, host cyclophilin, a prolyl isomerase, binds to
Vpr at proline in the first turn and is important for stable Vpr
expression (Zander et al., 2003). Preliminary evidence demon-
strates an analogous dependence of HIV-2 Vpx on cyclophilin,
substantiating the idea that the conformation of Vpx may be
similar to Vpr (data not shown).
At this time, the function of a leucine zipper for Vpr remains
unclear. In any event, based on the modeling discussed here, it
seems unlikely that Vpx would be able to adopt an analogous
dimer involving helix three. This potential structural difference
might reflect differing functions. For example, Vpr has been
implicated in a wide array of activities not known for Vpx
including transcription activation, regulation of apoptosis, and
the well-characterized G2 arrest (reviewed in Le Rouzic and
Benichou, 2005).
Viral packaging
Surprisingly, the insertion mutations were broadly tolerated
for viral packaging in that mutating the helical domain or C-
terminus did not completely abrogate this function. However,
Vpx Ins 52 was severely compromised, suggesting that either
an intact helix two or exposed face of helix two is important
for the interaction with Gag. On the other hand, Ins 106
retained viral packaging, suggesting that the polyproline tail is
not critical for Gag binding. The helical model (Figs. 1E and
F) predicts a loop adjacent to Ins 57 and 71 and a linker
region at the site of Ins 91, between the helical domain and
the C-terminus. The mutants Ins 57, 71, and 91 retained
adequate viral packaging, suggesting that the loop and linker
are flexible enough to tolerate variation.
Previous studies have shown that Vpx or Vpr can tolerate a
wide range of mutations and still be packaged into virions. For
Vpx, the Gag interaction domain would appear to be located
between aa 64 and 89, since deletion N- or C-terminal to thesepositions, respectively, does not abrogate recruitment into
particles (Pancio et al., 2000; Mahalingam et al., 2001).
Furthermore, internal deletion of aa 73–89 did not disrupt
viral particle incorporation (Jin et al., 2001). This would leave
aa 64–73 as a possible minimal Gag interaction domain, which
coincides with the loop and the NLS in the model of the protein
described here. However, in a previous study, SIV Vpx aa 60–
85 fused to GFP was found to be insufficient for viral particle
localization (Mahalingam et al., 2001). Ins 71 supports this
observation, in that the mutant protein could still be packaged.
In terms of the overall three helix bundle, a previous study
showed that mutating the extremely conserved histidine at
position 82 did not affect viral packaging (Mahalingam et al.,
2001), a mutation which is predicted to disrupt the helical
bundle structure. Thus, it appears that neither an intact three
helix bundle, as modeled here, nor the NLS-loop region is
critical for viral packaging. The precise residues involved in
viral packaging remain to be determined.
Nuclear localization by GFP fusion assay
The phenotype of Vpx Ins 106 (Fig. 3) confirms a previous
result in which Vpx was truncated C-terminal to aa 110,
resulting in destabilization of nuclear localization (Pancio et al.,
2000). Thus, the highly conserved polyproline motif contributes
to efficient nuclear localization.
A surprising result was found with Ins 71. This mutation
disrupts the NLS motif, 65-SYTKYRYLCIM-75, as defined by
Belshan and Ratner (2003). Yet, the mutant localized uniformly
to the nucleus in the GFP assay (Fig. 3). In the study of Belshan
and Ratner, 3 aa at the C-terminal end of the peptide did not
seem necessary for the NLS function, given the fact that an 11-
aa sequence, aa 61–72, could also mediate nuclear localization.
Because the net effect of Ins 71 is to disrupt the motif after
position 71, the observations suggest that L72 is not critical for
the NLS signal. There may be various reasons contributing to
the good performance of Ins 71 in this assay including increased
solubility or an extended structure exposing the NLS. In fact,
Ins 71 did not form inclusion bodies in the GFP assay (Fig. 3).
In terms of sequence, the random 19-aa insertion caused
duplication of K/R-Y-R-Y (Fig. 2A), a motif that is very well
conserved among HIV-1/SIV isolates (Fig. 1G). Because a
recent study of SIV Vpx confirmed aa 61–80 to be sufficient for
nuclear entry and that mutation of K68A did not disrupt nuclear
localization (Rajendra Kumar et al., 2003), 69-YRY-71 may be
the most critical residues. For HIV-2 ROD Vpx, we have
recently demonstrated the importance of R70, when mutated
together with K68, and Y69 for the nuclear localization signal
(Belshan et al., in press).
PIC-associated nuclear localization by Alu integration
In this sensitive, non-dividing cell assay induced by serum
starvation, Vpx was observed to enhance PIC nuclear
localization (Fig. 4, lanes 1 and 2). The relative activities of
Ins 52, 57, 71, and 91 in this assay are similar to the relative
packaging efficiencies of these mutants as compared to wild
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effect of the mutations on PIC activity appears to be minimal.
The results confirm those of the GFP nuclear localization assay
in the case of Ins 52 and 71. Why Ins 57 behaves poorly in the
GFP assay is unclear but might be explained by toxic or
artifactual effects of overexpressing the mutant protein. Clearly,
overexpression of Ins 91 caused toxicity to the cells in the GFP
assay.
Ins 106 appeared to be severely compromised for PIC
function in the non-dividing cell assay, suggesting an important
role of the polyproline motif in PIC-associated nuclear
localization. This result is in agreement with the destabilization
of nuclear localization observed in the GFP assay and confirms
previous observations mutating this C-terminal region (Pancio
et al., 2000).
An alternate test of PIC nuclear localization would be to test
the Vpx mutant viruses for infection of macrophages. However,
the ROD HIV-2 isolate is defective for efficient macrophage
infection for reasons that are unclear at this time.
Summary
One goal of these experiments is to identify regions in Vpx
that are suitable for intramolecular tagging. Insertion site 106
appears to be a poor candidate, given the disruption of both PIC
associated and GFP fusion nuclear localization. Ins 57 appears
to retain PIC activity and incorporates relatively well into viral
particles but performed poorly in the GFP assay, which may be
subject to artifact given the high levels of overexpressed
protein. Indeed, Ins 91 caused toxicity to cells in the GFP assay
but appeared to retain PIC integration activity as well as
adequate viral packaging. Finally, the phenotype of Ins 71 is
unexpected. The mutant sequence suggests that leucine at
position 72 is not important to the NLS. The mutant protein
showed strong nuclear localization as a free GFP fusion, was
non-toxic, did not form inclusion bodies, retained adequate viral
packaging, and appeared to be stable for PIC function. In
summary, the best candidates for stable insertion sites are
clustered around the NLS-loop region, near aa 57–71, or within
the helical domain/C-terminus linker, near aa 91.
Viruses have evolved a variety of strategies for harnessing
the nuclear pore. For HIV-2, the mechanism of nuclear
localization appears unique but remains poorly understood.
Characterizing the molecular details of retroviral preintegration
complexes and associated host interactions should highlight
novel therapeutic targets as well as basic mechanisms of nuclear
entry.
Materials and methods
Homology modeling
Amino acids 23–87 in the HIV-2 ROD Vpx primary
sequence were aligned with residues 17–76 of HIV-1 Vpr by
Domain Fishing (Bates et al., 2001). The alignment resulted in 5
extra aa in Vpx, aa 62–66, coinciding with coil predicted by
PsiPred (McGuffin et al., 2000) in the region aa 56–66. Becausethe region is low complexity, we manually adjusted the
alignment by moving the gap to Vpx aa 60–64 and submitted
to 3D Jigsaw against PDB 187L (Morellet et al., 2003; Bates
and Sternberg, 1999; Bates et al., 2001; Contreras-Moreira and
Bates, 2002). To build the gap, a full-length alignment was
submitted to the Robetta/Rosetta modeling server against Vpr
PDB 187L (Kim et al., 2004; Chivian et al., 2003; Rohl et al.,
2004). For the third helix dimerization domain, Vpr coordinates
were kindly supplied by Bourbigot et al. (2005). The
corresponding region of Vpx was fit manually using Swiss-
PdbViewer (Schwede et al., 2003), and the dimer was modeled
by Swiss-Model. For Vpx consensus building, the Vpx HIV-2/
SIV alignment from the Los Alamos HIV sequence database,
http://www.hiv.lanl.gov/content/hiv-db/mainpage.html, was
converted into a sequence logo (Crooks et al., 2004). The
height of the letters represents the relative frequency of that
residue at the given position (Schneider and Stephens, 1990).
For Vpx/Vpr remote homology sensing by hidden Markov
models, the SAM-99 server, http://www.cse.ucsc.edu/research/
compbio/sam.html, was used (Karplus et al., 1998; Krogh et al.,
1994; Hughey and Krogh, 1996).
Proviral constructs
A subcloning cassette containing a 587 bp fragment of the
ROD10 (Bour et al., 1996) proviral clone was used such that a
SacI site at bp 5704 has been mutated but does not alter the vpr
open reading frame (Pancio et al., 2000). A series of random
insertion mutations were made by the method of EZ:Tn
(Epicentre, Madison, WI) (Goryshin and Reznikoff, 1998).
After sequencing, candidate insertions were chosen, and the
bulk of the transposon was removed by restriction digestion
with NotI followed by religation. This procedure leaves random
19-aa insertions in every reading frame, with 9 bp of the original
DNA sequence duplicated at either end. The modified regions
were then digested with SacI and cloned into the ROD10 vector.
The polyhistidine mutant was constructed using mutagenic
primers coding for five histidines adjacent to the natural
histidine at position 57 using the QuikChange method
(Stratagene, La Jolla, CA). The ΔVpx construct contains
mutations at the initiating and first internal methionines of Vpx
such that the reading frame of vpr is intact (Hu et al., 1989).
Transfections, viral particle isolation, and Western blotting
293T cells were transfected with proviral DNA in Dulbec-
co's modified Eagle's Medium (DMEM) supplemented with
10% fetal calf serum and antibiotics, using Transit-LTI (Mirus
Bio, Madison, WI) according to the manufacturer's directions.
AT 72 h, the supernatant was cleared by low speed
centrifugation, layered on 20% sucrose, and subjected to
ultracentrifugation at 26,000×g for 90 min. The pellet was
resuspended in SDS-PAGE sample buffer, boiled for 10 min in
the presence of DTT, and loaded on Tris–tricine SDS-PAGE.
After blotting onto PVDF membranes, the blots were probed
with a monoclonal anti-Vpx antibody (NIH AIDS Research and
Reference Reagent Program, 6D2.6) or an anti-p24 capsid
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which had been previously purified on protein A sepharose
beads (Sigma, St. Louis, MO) from hybridoma culture. The
blots were developed with anti-mouse horseradish peroxidase
antibody followed by SuperSignal West Femto substrate
(Pierce, Rockford, IL) and imaged and quantitated on
chemiluminescent Alpha Imager (Alpha Innotech, San Leandro,
CA). For the cellular lysates, the 293T cells were lysed in SDS
sample buffer and loaded onto 12% Tris SDS-PAGE, followed
by Western blotting.
GFP fusion nuclear localization
Insertion mutations were cloned into pEGFPC1 (Clontech)
using BamHI and EcoRI sites, resulting in fusion to the GFP
open reading frame at the Vpx N-terminus driven by a
constitutive CMV-based promoter. 105 HeLa cells grown on
coverslips were transfected with 2 μg of DNA in duplicate in
6-well tissue culture plates, DMEM medium supplemented
with 10% fetal calf serum and antibiotics, and Transit-LTI
(Mirus Bio, Madison, WI), according to the manufacturer's
instructions. After 16 h, the cells were fixed with 2%
paraformaldehyde, treated with 0.1% Triton X-100 for 5 min,
then stained with Hoechst 33258 (Molecular Probes, Eugene,
OR). The coverslips were mounted, and the cells were
visualized using a fluorescence microscope equipped with an
Optronics Magnafire imaging system (Optronics, Goleta, CA).
Multiple images were obtained and compared from three
independent transfections.
Alu integration assay
Amphotropic MLV pseudotyped HIV-2 ROD viruses were
prepared by transfection of 293T cells in the presence of 1:5 μg
ratio of a CMV driven amphotropic MLV env plasmid DNA to
molecular clone ROD DNA using Transit-LTI in DMEM
medium supplementedwith 10% fetal calf serum and antibiotics,
according to the manufacturer's directions. After 72 h, the
supernatants were cleared by low-speed centrifugation, and viral
particles were quantitated by simian immunodeficiency virus
ELISA (Coulter, Miami, FL). U937 monocyte cells (ATCC
CRL-1593.2) were plated at 106 cells per well in 12-well tissue
culture dishes after washing and diluting in 0% fetal calf serum
RPMI-1640 media (Gibco, Grand Island, NY) supplemented
with antibiotics. After 48 h, 100 ng virus was added, and the
reactions were incubated for 4 h at 37 °C in a humidified, CO2
supplemented incubator. The cells were washed in phosphate-
buffered saline and genomic DNA was prepared using the
Qiagen (Valencia, CA) Mini Blood DNA kit. A linear round of
PCR was performed for 12 cycles, with 3-min extension, 60 °C
annealing temperature and the following primers: ATGCCACG-
TAAGCGAAACTGC GAGGCTGGCAGATTGAGCCCTG,
which contains a 5′ tag sequence (underlined) and is
complementary at the 3′ end to the HIV-2 ROD LTR;
TCCCAGCTACTGGGGAGGCTGAGG, an Alu complemen-
tary primer; and GCCTCCCAAAGTGCTGGGATTACAG, an
Alu complementary primer. A quantitative real-time round wasthen performed using iQ Supermix (Biorad, Hercules, CA), 60
°C annealing temperature, 30-s extension, and the following
primers: ATGCCACGTAAGCGAAACTGC, containing the tag
sequence; TTACTCAGGTGAACACCGAATGACCAGGC,
complementary to the HIV-2 LTR; and 5′-FAM-TCCCAT-
CTCTCCTAGTCGCCGCCT-3′-Iowa Black, as a probe. The
standards were dilutions of genomic DNA prepared in the same
way from U937 cells chronically infected with ROD HIV-2.
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